5-128537536-G-C
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_001999.4(FBN2):āc.68C>Gā(p.Ala23Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000322 in 1,590,704 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001999.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152104Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000177 AC: 37AN: 208522Hom.: 0 AF XY: 0.000193 AC XY: 22AN XY: 114164
GnomAD4 exome AF: 0.000343 AC: 494AN: 1438600Hom.: 0 Cov.: 32 AF XY: 0.000346 AC XY: 247AN XY: 714138
GnomAD4 genome AF: 0.000125 AC: 19AN: 152104Hom.: 0 Cov.: 33 AF XY: 0.0000808 AC XY: 6AN XY: 74282
ClinVar
Submissions by phenotype
Congenital contractural arachnodactyly Benign:2
- -
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
FBN2-related disorder Uncertain:1
The FBN2 c.68C>G variant is predicted to result in the amino acid substitution p.Ala23Gly. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.036% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/5-127873229-G-C), which may be too frequent for an unreported disease-causing variant. In ClinVar, this variant has conflicting interpretations regarding its pathogenicity, ranging form uncertain to likely benign. The majority of congenital contractural arachnodactyly-causative variants in FBN2 substitute a cysteine residue to another amino acid and reside in the 13th to 23rd calcium binding-epidermal growth factor (cbEGF) like domains (Callewaert et al. 2009. PubMed ID: 19006240; uniprot.org). The p.Ala23Gly change does not reside in a cbEGF- like domain and does not alter a cysteine residue. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Familial thoracic aortic aneurysm and aortic dissection Uncertain:1
The p.A23G variant (also known as c.68C>G), located in coding exon 1 of the FBN2 gene, results from a C to G substitution at nucleotide position 68. The alanine at codon 23 is replaced by glycine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
not provided Benign:1
See Variant Classification Assertion Criteria. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at